Expression analysis of dopamine receptor subtypes in normal human pituitaries, nonfunctioning pituitary adenomas and somatotropinomas, and the association between dopamine and somatostatin receptors with clinical response to octreotide-LAR in acromegaly

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 6, 2009, Pages 1931-1937

  Neto, Leonardo Vieira ^a   Machado, Evelyn De O ^a   Luque, Raul M ^e,f   Taboada, Giselle F ^a   Marcondes, Jorge B ^a   Chimelli, Leila M C ^a   Quintella, Leonardo Pereira ^b   Niemeyer Jr , Paulo ^c   De Carvalho, Denise P ^a   Kineman, Rhonda D ^f   Gadelha, Mônica R ^a,d,g  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Funda??o Oswaldo Cruz   (Brazil)

^c Neurosurgery Section   (Brazil)

^d Instituto Estadual de Diabetes e Endocrinologia Luiz Capriglione   (Brazil)

^e UNIVERSITY OF CÓRDOBA   (Spain)

^f UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^g Rua Nascimento Silva   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR; GROWTH HORMONE; MESSENGER RNA; OCTREOTIDE; PROLACTIN; SOMATOMEDIN C; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR 1; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 3; SOMATOSTATIN RECEPTOR 4; SOMATOSTATIN RECEPTOR 5;

ACROMEGALY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE SECRETING ADENOMA; HUMAN; HUMAN TISSUE; HYPOPHYSIS; IN VIVO STUDY; MAJOR CLINICAL STUDY; NONFUNCTIONING PITUITARY ADENOMA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; TREATMENT RESPONSE; TUMOR VOLUME;

EID: 66749176715     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-1826     Document Type: Article

References (46)

1. Colao A, Filippella M, Pivonello R, Di Somma C, Faggiano A, Lombardi G 2007 Combined therapy of somatostatin analogues and dopamine agonists in the treatment of pituitary tumours. Eur J Endocrinol 156(Suppl 1):S57-S63 (Pubitemid 46797845)
2. Ferone D, Pivonello R, Resmini E, Boschetti M, Rebora A, Albertelli M, Albanese V, Colao A, Culler MD, Minuto F 2007 Preclinical and clinical experiences with the role of dopamine receptors in the treatment of pituitary adenomas. Eur J Endocrinol 156(Suppl 1):S37-S43 (Pubitemid 46797842)
3. Saveanu A, Jaquet P 24 July 2008 Somatostatin-dopamine ligands in the treatment of pituitary adenomas. Rev Endocr Metab Disord 10.1007/s11154-008- 9086-9090
4. Civelli O, Bunzow JR, Grandy DK 1993 Molecular diversity of the dopamine receptors. Annu Rev Pharmacol Toxicol 33:281-307 (Pubitemid 23116009)
5. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG 1998 Dopamine receptors: from structure to function. Physiol Rev 78:189-225 (Pubitemid 28070979)
6. Renner U, Arzberger T, Pagotto U, Leimgruber S, Uhl E, Müller A, Lange M, Weindl A, Stalla GK 1998 Heterogeneous dopamine D2 receptor subtype messenger ribonucleic acid expression in clinically nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 83:1368-1375 (Pubitemid 28496421)
7. Van Tol HH, Wu CM, Guan HC, Ohara K, Bunzow JR, Civelli O, Kennedy J, Seeman P, Niznik HB, Jovanovic V 1992 Multiple dopamine D4 receptor variants in the human population. Nature 358:149-152 (Pubitemid 23137500)
8. Caron MG, Beaulieu M, Raymond V, Gagné B, Drouin J, Lefkowitz RJ, Labrie F 1978 Dopaminergic receptors in the anterior pituitary gland. Correlation of [3H]dihydroergocryptine binding with the dopaminergic control of prolactin release. J Biol Chem 253:2244-2253 (Pubitemid 8328208)
9. Cronin MJ, Thorner MO, Hellmann P, Rogol AD 1984 Bromocriptine inhibits growth hormone release from rat pituitary cells in primary culture. Proc Soc Exp Biol Med 175:191-195 (Pubitemid 14194057)
10. Foord SM, Peters JR, Dieguez C, Scanlon MF, Hall R 1983 Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin. Endocrinology 112:1567-1577
11. Goldsmith PC, Cronin MJ, Weiner RI 1979 Dopamine receptor sites in the anterior pituitary. J Histochem Cytochem 27:1205-1207 (Pubitemid 9246262)
12. Ferone D, de Herder WW, Pivonello R, Kros JM, van Koetsveld PM, de Jong T, Minuto F, Colao A, Lamberts SW, Hofland LJ 2008 Correlation of in vitro and in vivo somatotropic adenoma responsiveness to somatostatin analogs and dopamine agonists with immunohistochemical evaluation of somatostatin and dopamine receptors and electron microscopy. J Clin Endocrinol Metab 93:1412-1417
13. Pivonello R, Matrone C, Filippella M, Cavallo LM, DiSomma C, Cappabianca P, Colao A, Annunziato L, Lombardi G 2004 Dopamine receptor expression and function in clinically nonfunctioning pituitary tumors: comparison with the effectiveness of cabergoline treatment. J Clin Endocrinol Metab 89:1674-1683 (Pubitemid 38507920)
14. Saveanu A, Gunz G, Guillen S, Dufour H, Culler MD, Jaquet P 2006 Somatostatin and dopamine-somatostatin multiple ligands directed towards somatostatin and dopamine receptors in pituitary adenomas. Neuroendocrinology 83:258-263 (Pubitemid 44578880)
15. Caccavelli L, Feron F, Morange I, Rouer E, Benarous R, Dewailly D, Jaquet P, Kordon C, Enjalbert A 1994 Decreased expression of the two D2 dopamine receptor isoforms in bromocriptine-resistant prolactinomas. Neuroendocrinology 60:314-322 (Pubitemid 2119106)
16. Ferone D, Pivonello R, Lastoria S, Faggiano A, Del Basso de Caro ML, Cappabianca P, Lombardi G, Colao A 2001 In vivo and in vitro effects of octreotide, quinagolide and cabergoline in four hyperprolactinaemic acromegalics: correlation with somatostatin and dopamine D2 receptor scintigraphy. Clin Endocrinol (Oxf) 54:469-477
17. Stefaneanu L, Kovacs K, Horvath E, Buchfelder M, Fahlbusch R, Lancranjan L 2001 Dopamine D2 receptor gene expression in human adenohypophysial adenomas. Endocrine 14:329-336 (Pubitemid 32547815)
18. Baragli A, Alturaihi H, Watt HL, Abdallah A, Kumar U 2007 Heterooligomerization of human dopamine receptor 2 and somatostatin receptor 2 co-immunoprecipitation and fluorescence resonance energy transfer analysis. Cell Signal 19:2304-2316 (Pubitemid 47361686)
19. Rocheville M, Lange DC, Kumar U, Patel SC, Patel RC, Patel YC 2000 Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science 288:154-157 (Pubitemid 30203051)
20. Zatelli MC, Piccin D, Tagliati F, Bottoni A, Ambrosio MR, Margutti A, Scanarini M, Bondanelli M, Culler MD, degli Uberti EC 2005 Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitro. J Mol Endocrinol 35:333-341
21. Ferone D, Saveanu A, Culler MD, Arvigo M, Rebora A, Gatto F, Minuto F, Jaquet P 2007 Novel chimeric somatostatin analogs: facts and perspectives. Eur J Endocrinol 156(Suppl 1):S23-S28 (Pubitemid 46797840)
22. Taboada GF, Luque RM, Bastos W, Guimarães RF, Marcondes JB, Chimelli LM, Fontes R, Mata PJ, Filho PN, Carvalho DP, Kineman RD, Gadelha MR 2007 Quantitative analysis of somatostatin receptor subtype (SSTR1-5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas. Eur J Endocrinol 156:65-74 (Pubitemid 46553904)
23. Taboada GF, Luque RM, Neto LV, Machado Ede O, Sbaffi BC, Domingues RC, Marcondes JB, Chimelli LM, Fontes R, Niemeyer P, de Carvalho DP, Kineman RD, Gadelha MR 2008 Quantitative analysis of somatostatin receptor subtypes (1-5) gene expression levels in somatotropinomas and correlation to in vivo hormonal and tumor volume responses to treatment with octreotide LAR. Eur J Endocrinol 158:295-303
24. Gandelman KY, Harmon S, Todd RD, O'Malley KL 1991 Analysis of the structure and expression of the human dopamine D2A receptor gene. J Neurochem 56:1024-1029 (Pubitemid 21922718)
25. Mack KJ, Todd RD, O'Malley KL 1991 The mouse dopamine D2A receptor gene: sequence homology with the rat and human genes and expression of alternative transcripts. J Neurochem 57:795-801
26. Guivarc'h D, Vincent JD, Vernier P 1998 Alternative splicing of the D2 dopamine receptor messenger ribonucleic acid is modulated by activated sex steroid receptors in the MMQ prolactin cell line. Endocrinology 139:4213-4221 (Pubitemid 28513708)
27. Dal Toso R, Sommer B, Ewert M, Herb A, Pritchett DB, Bach A, Shivers BD, Seeburg PH 1989 The dopamine D2 receptor: two molecular forms generated by alternative splicing. EMBO J 8:4025-4034 (Pubitemid 20066843)
28. Arnauld E, Arsaut J, Demotes-Mainard J 1991 Differential plasticity of the dopaminergic D2 receptor mRNA isoforms under haloperidol treatment, as evidenced by in situ hybridization in rat anterior pituitary. Neurosci Lett 130:12-16
29. Giros B, Sokoloff P, Martres MP, Riou JF, Emorine LJ, Schwartz JC 1989 Alternative splicing directs the expression of two D2 dopamine receptor isoforms. Nature 342:923-926 (Pubitemid 20021338)
30. Inoue A, Seto M, Sugita S, Hide I, Hirose T, Koga N, Kikuchi T, Nakata Y 1998 Differential effects on D2 dopamine receptor and prolactin gene expression by haloperidol and aripiprazole in the rat pituitary. Brain Res Mol Brain Res 55:285-292 (Pubitemid 28248045)
31. O'Malley KL, Mack KJ, Gandelman KY, Todd RD 1990 Organization and expression of the rat D2A receptor gene: identification of alternative transcripts and a variant donor splice site. Biochemistry 29:1367-1371 (Pubitemid 20063362)
32. Rao DD, McKelvy J, Kebabian J, MacKenzie RG 1990 Two forms of the rat D2 dopamine receptor as revealed by the polymerase chain reaction. FEBS Lett 263:18-22 (Pubitemid 20107769)
33. Byrnes EM, Bridges RS 2007 Reproductive experience and expression of dopamine D(2) receptor mRNA: a possible mechanism for reduced prolactin secretion in primiparous rats. J Neuroendocrinol 19:773-778
34. Dutton MD, Varhol RJ, Dixon DG 1995 Technical considerations for the use of ethidium bromide in the quantitative analysis of nucleic acids. Anal Biochem 230:353-355
35. Choi EY, Jeong D, Park KW, Baik JH 1999 G protein-mediated mitogenactivated protein kinase activation by two dopamine D2 receptors. Biochem Biophys Res Commun 256:33-40 (Pubitemid 29298912)
36. Hayes G, Biden TJ, Selbie LA, Shine J 1992 Structural subtypes of the dopamine D2 receptor are functionally distinct: expression of the cloned D2A and D2B subtypes in a heterologous cell line. Mol Endocrinol 6:920-926
37. Senogles SE 2000 The D2s dopamine receptor stimulates phospholipase D activity: a novel signaling pathway for dopamine. Mol Pharmacol 58:455-462 (Pubitemid 30497491)
38. Abs R, Verhelst J, Maiter D, Van Acker K, Nobels F, Coolens JL, Mahler C, Beckers A 1998 Cabergoline in the treatment of acromegaly: a study in 64 patients. J Clin Endocrinol Metab 83:374-378 (Pubitemid 28496509)
39. Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van Tol HH 1995 Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem 65:1157-1165
40. De Keyser J, Dierckx R, Vanderheyden P, Ebinger G, Vauquelin G 1988 D1 dopamine receptors in human putamen, frontal cortex and calf retina: differences in guanine nucleotide regulation of agonist binding and adenylate cyclase stimulation. Brain Res 443:77-84 (Pubitemid 18062774)
41. Lezcano N, Bergson C 2002 D1/D5 dopamine receptors stimulate intracellular calcium release in primary cultures of neocortical and hippocampal neurons. J Neurophysiol 87:2167-2175 (Pubitemid 34670778)
42. Sanyal S, Van Tol HH 1997 Dopamine D4 receptor-mediated inhibition of cyclic adenosine 3′,5′-monophosphate production does not affect prolactin regulation. Endocrinology 138:1871-1878 (Pubitemid 27180801)
43. Liu YF, Civelli O, Zhou QY, Albert PR 1992 Cholera toxin-sensitive 3′,5′-cyclic adenosine monophosphate and calcium signals of the human dopamine-D1 receptor: selective potentiation by protein kinase A. Mol Endocrinol 6:1815-1824
44. Kostenis E, Waelbroeck M, Milligan G 2005 Techniques: promiscuous Gα proteins in basic research and drug discovery. Trends Pharmacol Sci 26:595-602 (Pubitemid 41505228)
45. Pivonello R, Ferone D, Lombardi G, Colao A, Lamberts SW, Hofland LJ 2007 Novel insights in dopamine receptor physiology. Eur J Endocrinol 156(Suppl 1):S13-S21 (Pubitemid 46797839)
46. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F 2002 Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:RESEARCH0034